• Avazova T.A., Ziyadullaev Sh.Kh., Akhmedov I.A.
  Samarkand State Medical University, Republic of Uzbekistan, Samarkand

Abstract

40 persons with MS were examined. All persons determined by the content IL-6, IL -17 in the blood serum before and after immune disorders correctiveby Ursosan forte. It is established that the MS increases the level of IL-6 and IL-17. The therapy had a positive impact on cytokine status.

Keywords

metabolic syndrome, immune disorders, ursosan, cytokine status.

Literature

1. Шварц В. Регуляция метаболических процес-сов интерлейкина 6. Журнал «Цитокины и воспа-ление»,№3,2009,с.3-10 2. Пирогова И.Ю., Яковлева С.В., Неуймина Т.В. и др. Плейотропные эффекты урсодезоксихолевой кислоты при неалкогольной жировой болезни пе-чени и метаболическом синдроме. Consilium Medicum. 2019; 21 (8): 65–70. DOI: 10.26442/20751753.2019.8.190365 3. Ризаев Ж. А., Юлдошева Ш. А., Мамасолиева Ш. А. Формирования и улучшения здорового об-раза жизни у студентов высших учебных заведе-ний // Журнал биомедицины и практики. – 2022. – Т. 7. – №. 3. 4. Ризаев Ж. А. и др. Значение коморбидных со-стояний в развитии хронической сердечной не-достаточности у больных пожилого и старческого возраста // Достижения науки и образования. – 2022. – №. 1 (81). – С. 75-79.

5. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity /// J Am SocNephrol – 2014 – 15: 2792–80
6. Халимова Х.М., Меметов Ф.Ю., Раимова М.М. Динамика показателей клетлчного т гуморального иммунитета у больных с ишемическим инсультом на фоне лечения «TAF»Лактофлором./ Вестник Казахского национального медицинского универ-ситета, №4,2015, с.232-233
7. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evalua-tion, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final Report. Circulation 106, 3143-3421 (2012). The 2001 NCEP report sparked increased interest of the medical community in the metabolic syndrome. It led to new research as well as controversy about the clinical utility of the syndrome.
8. Grundy, S. M. et al. Definition of metabolic syn-drome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433-438 (2014).
9. Grundy, S. M. et al. Clinical management of met-abolic syndrome: report of the American Heart Asso-ciation/ National Heart, Lung, and Blood Institute/ American Diabetes Association conference on scien-tific issues related to management. Circulation 109, 551-556 (2014).
10. Eckel, R. H., Grundy, S. M. &Zimmet, P. Z. The metabolic syndrome: epidemiology, mechanisms, and therapy. Lancet 365, 1415-1428 (2015). Reviews the worldwide epidemiology, pathophysiology and man-agement of the metabolic syndrome.
11. Rizaev J. A., Khaidarov N. K., Abdullaev S. Y. Current approach to the diagnosis and treatment of glossalgia (literature review) // World Bulletin of Public Health. – 2021. – Т. 4. – С. 96-98.

11. Rizaev J. A., Khaidarov N. K., Abdullaev S. Y. Current approach to the diagnosis and treatment of glossalgia (literature review) // World Bulletin of Public Health. – 2021. – Т. 4. – С. 96-98.
12. Rizaev J. A., Rizaev E. A., Akhmadaliev N. N. Current view of the problem: A new approach to COVID-19 treatment // Indian Journal of Forensic Medicine & Toxicology. – 2020. – Т. 14. – №. 4. – С. 7341-7347.
13. Rizaev J. A., Maeda H., Khramova N. V. Plastic surgery for the defects in maxillofacial region after surgical resection of benign tumors // Annals of Can-cer Research and Therapy. – 2019. – Т. 27. – №. 1. – С. 22-23.
14. Rizaev J. A., Kuliev O. A. Risk factors of anemia in children and prognosing of it // Электронный инновационный вестник. – 2018. – №. 4. – С. 62-65.
15. Rizaev J. A., Shodmonov A. A. Optimization of the surgical stage of dental implantation based on computer modeling // World Bulletin of Public Health. – 2022. – Т. 15. – С. 11-13.

16. Rizaev J. A., Umirzakov Z. B. B., Umirov S. E. Ways to Optimize Medical Services for Covid-19 Patients //Special Education. – 2022. – Т. 1. – №. 43.
17. Rizaev J. A., Bekmuratov L. R. Prevention of tis-sue resorption during immediate implant placement by using socket shield technique // Art of Medicine. International Medical Scientific Journal. – 2022. – Т. 2. – №. 3.
18. Rizaev J. A., Maxmudova A. N. Bioetika zamonaviy madaniyatda indviduallikni himoya qilish shakli sifatida // Academic research in educational sciences. – 2022. – №. 2. – С. 64-68.
19. McNeill, A. M. et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. DiabetesCare 28, 385-390 (2015).
20. Solymoss, B. C. et al. Incidence and clinical char-acteristics of the metabolic syndrome in patients with coronary artery disease. Coron. ArteryDis. 14, 207-212 (2013).

21. Grundy, S. M. et al. Diagnosis and management of the metabolic syndrome. An American Heart Associ-ation/ National Heart, Lung, and Blood Institute Sci-entific Statement. Circulation 112, 2735–2752 (2015).